Quantification of area at risk in acute myocardial infarction by tomographic imaging

Journal of Nuclear Medicine

Volumn 38, Issue 12, 1997, Pages 1875-1882

  Furutani, Yuhji ^a   Shiigi, Toshiaki ^b   Nakamura, Yasuma ^b   Nakamura, Hiroshi ^b   Harada, Masahiko ^b   Yamamoto, Takeshi ^b   Wakeyama, Takatoshi ^b   Nakatsuka, Masami ^b   Ogawa, Hiroshi ^b   Matsuzaki, Masunori ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Acute myocardial infarction; Area at risk; BMIPP

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART INFARCTION SIZE; HEART VENTRICULOGRAPHY; HUMAN; HYPOKINESIA; IMAGE ANALYSIS; MALE; PHANTOM; PRIORITY JOURNAL; RISK ASSESSMENT;

CORONARY ANGIOGRAPHY; FATTY ACIDS; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; OBSERVER VARIATION; PHANTOMS, IMAGING; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031444938     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Knapp FF Jr, Kropp J. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361-381.
2. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
3. Tamaki N, Kawamoto M, Yonekura Y, et al. Assessment of fatty acid metabolism using 1-123 branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7:S41-S47.
4. Saito S, Yasuda T, Gold HK, et al. Differentiation of regional perfusion and fatty acid uptake in zones of myocardial injury. Nucl Med Commun 1991;12:663-675.
5. 123I-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21: 283-291.
6. Franken PR, Geeter FD, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-1765.
7. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995;36:1022-1030.
8. 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989;80:1277-1286.
9. Gibbons RJ, Christian TF, Hopfenspirger M, et al. Myocardial at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention. J Am Coll Cardiol 1994;24:616-623.
10. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992;86:81-90.
11. O'Connor MK, Hammell T, Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium-99m (sestamibi). Eur J Nucl Med 1990;17:69-76.
12. Dudczak R, Schmoliner R, Angelberger P, et al. Structurally modified fatty acids: clinical potential as tracers of metabolism. Eur J Nucl Med 1986;12:S45-S48.
13. Sandler H, Dodge HT. The use of single plane angiocardiography for the measurement of left ventricular volume in man. Am Heart J 1968;75:325-334.
14. Sheehan FH, Schofer J, Mathey DG, et al. Measurement of regional wall motion from biplane contrast ventriculograms: a comparison of the 30 degree right anterior oblique and 60 degree left anterior oblique projections in patients with acute myocardial infarction. Circulation 1986;74:796-804.
15. Sheehan FH, Schmidt WG, Bolson E. Influence of coronary arterial thrombus location on left ventricular function in acute myocardial infarction. Am J Cardiol 1990;66:16-21.
16. Christian TF, O'Connor MK, Hopfenspirger MR, et al. Comparison of reinjection thallium 201 and resting technetium-99m sestamibi tomographic images for the quantification of infarct size after acute myocardial infarction. J Nucl Cardiol 1994;1:17-28.
17. O'Connor MK, Gibbons RJ, Juni JE, et al. Quantitative myocardial SPECT for infarct sizing: feasibility of a multicenter trial evaluated using a cardiac phantom. J Nucl Med 1995;36:1130-1136.
18. Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study: comparison of unconscious and conscious dog models. Circ Res 1985;56:651-665.
19. Feiring AJ, Johnson MR, Kioschos JM, et al. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation 1987;75:980-987.
20. Ito H, Tomooka T, Sakai N, et al. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. Circulation 1993;87:355-362.
21. Nanto S, Masuyama T, Lim YJ, et al. Demonstration of functional border zone with myocardial contrast echocardiography in human hearts: simultaneous analysis of myocardial perfusion and wall motion abnormalities. Circulation 1993;88:447-453.
22. Ahrens PJ, Sheehan FH, Dahl J, et al. Extension of hypokinesia into angiographically perfused myocardium in patients with acute infarction. J Am Coll Cardiol 1993;22: 1010-1015.
23. Kropp J, Juergans M, Glaenzer KP, et al. Evaluation of ischemia and myocardial viability in patients with coronary artery disease (CAD) with iodine-123 labeled 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP). Ann Nucl Med 1993;7: 93-100.
24. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995;36:1043-1050.
25. Weinstein H, Reinhardt CP, Marcel R, et al. Myocardial redistribution of BMIPP [Abstract]. Circulation 1995;92:I-789.
26. Takeishi Y, Chiba J, Abe S, et al. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992;19:775-782.
27. Okada RD. Kinetics of thallium-201 in reperfused canine myocardium after coronary artery occlusion. J Am Coll Cardiol 1984;3:1245-1251.
28. Liu P, Burns R. Easy come, easy go: time to pause and put thallium reverse redistribution in perspective. J Nucl Med 1993;34:1692-1694.
29. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 1990;82:1424-1437.
30. Knabb RM, Bergmann SR, Fox KAA, et al. The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. J Nucl Med 1987;28:1563-1570.